Mission: Our mission is to build a global, patient-forward, cancer learning network where peer and professional navigators guide patients through the innovations of today’s molecular medicine.
View our program brochure here
Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer
Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer
Breaking Down Barriers to Diagnosis in AYA Patients With Lymphoma
Biomarker Testing Remains Crucial for Young Patients With Lung Cancer